Literature DB >> 2858698

Valproic acid associated abnormalities of carnitine metabolism.

J V Murphy, K M Marquardt, A L Shug.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1985        PMID： 2858698     DOI： 10.1016/s0140-6736(85)91481-3

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  10 in total

Review 1.  Biochemical relationships between Reye's and Reye's-like metabolic and toxicological syndromes.

Authors:  J Osterloh; W Cunningham; A Dixon; D Combest
Journal:  Med Toxicol Adverse Drug Exp       Date:  1989 Jul-Aug

2.  Heterozygotes for plasmalemmal carnitine transporter defect are at increased risk for valproic acid-associated impairment of carnitine uptake in cultured human skin fibroblasts.

Authors:  I Tein; S DiMauro; Z W Xie; D C De Vivo
Journal:  J Inherit Metab Dis       Date:  1995       Impact factor: 4.982

3.  Role of carnitine in disease.

Authors:  Judith L Flanagan; Peter A Simmons; Joseph Vehige; Mark Dp Willcox; Qian Garrett
Journal:  Nutr Metab (Lond)       Date:  2010-04-16       Impact factor: 4.169

Review 4.  Carnitine transport: pathophysiology and metabolism of known molecular defects.

Authors:  I Tein
Journal:  J Inherit Metab Dis       Date:  2003       Impact factor: 4.982

5.  Short-term effects of administration of anticonvulsant drugs on free carnitine and acylcarnitine in mouse serum and tissues.

Authors:  M F Camiña; I Rozas; M Gómez; J M Paz; C Alonso; S Rodriguez-Segade
Journal:  Br J Pharmacol       Date:  1991-05       Impact factor: 8.739

Review 6.  Valproate hepatotoxicity syndrome: hypotheses of pathogenesis.

Authors:  J R Stephens; R H Levy
Journal:  Pharm Weekbl Sci       Date:  1992-06-19

7.  Plasma and hepatic carnitine and coenzyme A pools in a patient with fatal, valproate induced hepatotoxicity.

Authors:  S Krähenbühl; G Mang; H Kupferschmidt; P J Meier; M Krause
Journal:  Gut       Date:  1995-07       Impact factor: 23.059

Review 8.  Science review: carnitine in the treatment of valproic acid-induced toxicity - what is the evidence?

Authors:  Philippe E R Lheureux; Andrea Penaloza; Soheil Zahir; Mireille Gris
Journal:  Crit Care       Date:  2005-06-10       Impact factor: 9.097

9.  Valproic-induced Fanconi syndrome: Clinical features, risk factors, diagnosis and management.

Authors:  Chunjiang Wang; Yulu Zhou; Liying Song; Zhenzhen Deng; Weijin Fang
Journal:  Front Med (Lausanne)       Date:  2022-09-16

10.  Carnitine and/or Acetylcarnitine Deficiency as a Cause of Higher Levels of Ammonia.

Authors:  Cecilia Maldonado; Natalia Guevara; Cecilia Queijo; Raquel González; Pietro Fagiolino; Marta Vázquez
Journal:  Biomed Res Int       Date:  2016-02-21       Impact factor: 3.411
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.